Zivo Bioscience to Present at the 8th Annual Dawson James Small Cap Growth Conference

Zivo Bioscience, a leading biotech/agtech R&D company, has announced that its management team will be delivering a company presentation and holding investor meetings at the highly anticipated 8th Annual Dawson James Small Cap Growth Conference. The event is scheduled to take place on Thursday, October 12, 2023, at the Wyndham Grand Jupiter at Harbourside Place in Jupiter, Florida.

Investors who are interested in arranging a meeting with Zivo Bioscience’s management team are encouraged to contact Tirth Patel at LHA Investor Relations. This conference provides an excellent opportunity for investors to gain insights into the company’s latest developments and future plans.

Zivo Bioscience is a research and development company that focuses on developing therapeutic, medicinal, and nutritional product candidates derived from proprietary algal cultures. With an impressive intellectual property portfolio, including proprietary algal and bacterial strains, biologically active molecules and complexes, and patented or patent-pending inventions, the company is at the forefront of innovation in the field of human and animal health.

The company’s product candidates have shown great potential to generate revenues, and Zivo Bioscience is committed to advancing its research and development efforts to bring these products to market. While there are inherent uncertainties in the development process, Zivo Bioscience remains confident in its ability to meet the expected demand and commercialize its products in a timely manner.

Zivo Bioscience’s participation in the 8th Annual Dawson James Small Cap Growth Conference highlights its commitment to engaging with investors and showcasing its cutting-edge advancements in the biotech/agtech industry. The conference serves as a platform for industry leaders, investors, and stakeholders to come together and explore potential partnerships and investment opportunities.

As Zivo Bioscience continues to make strides in its research and development initiatives, it remains dedicated to protecting its intellectual property rights and complying with regulatory requirements. The company’s mission is to improve the health and well-being of both humans and animals through the development of innovative and sustainable solutions.

For more information about Zivo Bioscience and its groundbreaking work, please visit their website at www.zivobioscience.com.